糖化概述:分子机制,对蛋白质的影响,病原和抑制
Ana Belén Uceda1, Laura Mariño1, Rodrigo Casasnovas1
1Departament de Química, Universitat de Les Illes Balears, Health Research Institute of the Balearic Islands (IdISBa), Ctra. Valldemossa Km 7.5, 07122 Palma, Spain.
Biophysical reviews
|May 13, 2024
概括
糖化是一种非酶体过程,形成先进的糖化最终产品 (AGEs),有助于糖尿病和心血管问题等疾病. 抑制糖化可以为这些疾病提供治疗潜力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 病理生理学 病理生理学
背景情况:
- 糖化是一种非酶的反应,在生物分子上形成先进的糖化终产物 (AGEs).
- 这一过程在高血糖条件下加剧,并与衰老和慢性疾病有关.
研究的目的:
- 为了提供一个全面的概述的糖化.
- 阐明糖化作用的机制,目标和后果.
- 讨论与糖化相关的疾病和当前的治疗策略.
主要方法:
- 关于糖化现有文献的综述.
- 关于糖化机制和分子标的详细解释.
- 讨论计算化学在理解糖化效应中的作用.
主要成果:
- 糖化会影响蛋白质的结构,功能和聚合,导致各种病理.
- AGE积累与肥胖,糖尿病,心血管,神经和脏疾病有关.
- 内源性防御机制和外源性抑制剂在控制糖化中起作用.
结论:
- 糖化是许多疾病的重要因素.
- 了解糖化途径对于开发向疗法至关重要.
- 抑制糖化是一种有前途的治疗途径.
相关概念视频
Protein Glycosylation
6.9K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
6.9K
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Overview of Carbohydrate Metabolism
944
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
944
Pathophysiology of Diabetes
921
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
921
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Hypoglycemia and Glucagon
257
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
257


